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Résumé en
anglais
Prior to possible introduction of large-scale vaccination programmes, an estimation
and comparison of naturally acquired immunity against Haemophilus influenzae type
b (Hib) was carried out in two populations of age-stratified infants and children (from
birth to 14 years old) in Burkina-Faso (West Africa) (n = 206) and France (n = 206).
Hib capsular polysaccharide antibodies were detected by an ELISA method. The
difference in the percentages of minimum protective levels for the two populations
were not significant (0.15 microg/ml) for newborns (0-1 month) but became
significant as early as 2 to 3 months of age (p < 0.01) when lower levels were found
among infants from Burkina-Faso. Subsequently, the percentages in both countries
remained low until 11 months of age and showed no significant differences. For
children between 12 and 35 months, the results > or = 0.15 microg/ml were
significantly higher in France (p < or = 0.05). From 36 months, the percentage of
minimum seropositivity increased in Burkina-Faso, so that the difference was no
longer significant. In each country, the percentage of children with the minimum
protective level varied significantly (p < or = 0.05) according to age (0-47 months).
None of the children from Burkina-Faso or France had antibody levels > 1.0
microg/ml before one year of age. Thereafter, only 9.51% of French children in the
12- to 17-month age stratum and 19.2% over 4 years of age had antibody levels > 1.0
microg/ml. There were no non-detectable results for children over 4 years of age, and
the means for natural detectable Hib CP antibodies were > 0.15 microg/ml for both
populations. Hib invasive infections depend on climate, socioeconomic status and
ethnic and genetic factors. In Burkina-Faso, the large number of infants and children
under 4 years of age susceptible to Hib infections suggests that large scale
vaccination programmes are needed soon after birth. However, it would first be
necessary to evaluate such factors as the frequency of Hib diseases in this
population.
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